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  It has been known that some of drugs， such as alkylating agents， have adverse effect on spermato－
genesis． Recently， salicylazosulfapyridine （SASP）， an effective drug to control ulcerative colitis，
has been suspected of reversible toxic effect on semen quality． ln 1979， Toth reported six paitents，
and Levi and Fisher did four other patients with SASP－treated chronic ulcerative colitis who had
poor semen qualities and barren marriage． Rapid improvement in semen quality and pregnancies
occurred after discontinua．tiQ．n．of SASP， and． reintroduction of the drUg was followed by rapid deterio－
ration in the semen． Such two patients were recently experienced in our clinic， who had severe oligo－
zoospermia and reduced spermatozoal motility and showed normal baseline levels of LH， FSH and
prolactin． We herein reported the cases in association with results of animal study disclosing that
SASP did not directly depress spermatogenesis of the testes on histological examination．
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Fig． 1． Barium enema in Case 1 showing disap－
    pearance of haustra coli and narrowing
    with irregularity and spicula formation of





























Fig． 2． Ph tomicrograph of a Papanicolaou－stained
    smear from a semen of Case 1． Ballooned
    or megalocell type of spermatozoa was not
    almost found．
Fig． 3． Barium enema in Case 2 showing linear
    ulceration and cobble stone appearance of
    descending colon in association with skip
    lesions of ulceration of ascending colon
    and transverse colon （arrow）．
桐山・ほか：salicylazosulfapyridine・乏精子症 925
Table 1． Findings of semen analysis in two Salazopyrin－treated patients
Case 1 2











































Table 2． Level of PGs in seminal plasma of Case 1．
Case A＋B（”g／ml） E（ptg／ml） F（”g／ml） HPr（ng／ml）
A． S， 0．了79 44．2 5．了6 8．5
Normospermia 1
       2































36 ngfml，5・07 ng／m1で， prolactin値がわずかに高
値を示した．また精漿中のprostaglandinの濃度は
Table 2に示すごとくA＋B O．779μ9／ml， E 44，2μ9





























colon PS skin test－immediate type （十）， delayed
type（一）一の結果はCrohn氏病を示すものであっ



















 方  法
 動物として130～1509のWistar系雄性ラットを
用いた．SASPの純末が入手不能のためSalazopyrin
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Table 4． Protocols of the study．
Fig． 4． Photomicrograph of a Papanicolaou－stained
    smear from a semen of Case 2． Ballooned
    or megalocell type of spermatozoa was not
    found also in this case．
Gr oup 1 〈 e in following figures）：
 on puユverized feed （Clea こrapan， NE－2｝
Gr◎up 工工 （◆）＝
 on 8Cimg Salarcpyrby20g the feed
Gromp工工1（▲）：
 on 20（img Sa］nzqnrrin／20g the feed
Each group ocrr1Er ised i2 male Wtstar rats．




























































100nt 2 4’SWFig．5． Effect of salicylazosulfapyridine on































fed。n 20（tP Saユaz。py・in／2〔ig feed
o 1 2 3 4 5 6 7 8W
Fig． 6． Growth curve （top） and gross specimen （bottom） of the rat （No．32）
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られなかった．Levi ct al．はlow or very low sperm







one， androstenedione， dihydrotestosterone， LH，
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Fig． 8． Gross specimens comprising testes， epididymides， spermatic ducts， seminal
    vesicle， prostate and urinary bladder． All specimens （except No．32） of Group
    II and Group III showed no abnormalities as compared with specimens of
    Group 1 （control） when sacrificed after 4－week （top） and 8－week （bottom）
    feed on Salazopyrin．
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Fig． 10． Effect of salcylazosulfapyridine on ratio
     of weight of testes／weight of accessory
     glands．
Fig． 9． Effect of salcylazosulfapyridine on weight
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                               Fig． 11－4
Fig． 11． Microscppic sections．of tgstes （1）， epidl’d．y． m． ideE．（th2）， prost．ates （3） apd semi．na！
        vesicles C4）． Note that there’iS’nJo d． efinite diffe．rehce－s bn etyreenhtbe contTol
        group （Gr’oup 1：B） and Group III （A） even after 8－week feed on Salazopyrin．
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Microscopic sections． of the ．testis （le－ft） ppd－the kidngy （right） of No．32．r4t
of which’垂?撃魔??and uretgrs i－mp4cted．with Salazopyrin． A．Sperrr｝4tggene．sis． is
not substintially damaged． ln’the kidney patchy areas of interstitial nephritis
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